CRT Recommendations

 

Cardiac Resynchronization Therapy (CRT): Indications

Introduction

Cardiac Resynchronization Therapy (CRT) is an established device-based treatment for patients with heart failure and electrical dyssynchrony, particularly in the setting of prolonged QRS duration. It improves symptoms, reduces hospitalizations, and decreases mortality in appropriately selected patients.

---

Pathophysiologic Basis

Ventricular dyssynchrony (especially with LBBB) → inefficient LV contraction

Reduced stroke volume and increased mitral regurgitation

CRT restores coordinated ventricular contraction → improves cardiac output

---

Core Indications (Guideline-Based)

Strong Indications (Class I)

CRT is recommended in patients with:

Symptomatic heart failure (NYHA class II–IV despite optimal medical therapy)

LVEF ≤35%

Sinus rhythm

Left bundle branch block (LBBB) morphology

QRS duration ≥150 ms

Key takeaway:

👉 Best responders = LBBB + wide QRS ≥150 ms

---

Moderate Indications (Class IIa)

CRT should be considered in:

LVEF ≤35%, NYHA II–IV

QRS 130–149 ms with LBBB

OR

Non-LBBB morphology with QRS ≥150 ms

OR

Atrial fibrillation with:

LVEF ≤35%

High RV pacing burden expected

AV nodal ablation or rate control to ensure near 100% pacing

---

Selected Indications (Class IIb)

CRT may be considered in:

QRS 130–149 ms with non-LBBB morphology

Patients requiring frequent ventricular pacing (>40%) with reduced EF

NYHA class I with ischemic cardiomyopathy, LVEF ≤30%, QRS ≥150 ms (selected cases)

---

CRT in Special Situations

1. Patients Requiring Pacing

Indicated if LVEF ≤50% and high expected RV pacing burden

Prevents pacing-induced cardiomyopathy

2. Atrial Fibrillation

Benefit depends on achieving high biventricular pacing (>95%)

Often requires AV nodal ablation

3. Post-MI / Ischemic Cardiomyopathy

Indications similar but response may be less robust than non-ischemic

---

Contraindications / Limited Benefit

QRS <120 ms → No benefit

Non-LBBB with narrow QRS

Advanced comorbidities limiting survival (<1 year)

Poor compliance with medical therapy

---

Predictors of Good Response

LBBB morphology

QRS ≥150 ms

Non-ischemic cardiomyopathy

Female sex

Absence of extensive scar

---

Predictors of Poor Response

Narrow QRS

Non-LBBB pattern

Severe RV dysfunction

Extensive myocardial scar

Suboptimal lead placement

---

CRT Devices

CRT-P: Pacemaker only

CRT-D: Combined with defibrillator

Choice depends on:

Sudden cardiac death risk

Ischemic vs non-ischemic etiology

Life expectancy

---

Practical Summary

Parameter Strong CRT Candidate

LVEF ≤35%

Rhythm Sinus rhythm

QRS ≥150 ms

Morphology LBBB

Symptoms NYHA II–IV

---

Clinical Pearls

Always optimize GDMT before CRT consideration

QRS morphology matters more than duration alone

Aim for >95% biventricular pacing

Echo dyssynchrony is not required for indication

---

Conclusion

CRT is a cornerstone therapy in selected heart failure patients with electrical dyssynchrony. Proper patient selection—especially focusing on LBBB morphology and QRS duration—is critical to maximize clinical benefit.